Basic information on Hyalein ophthalmic solution 0.1% has been published on Nikkei Medical Online, summarizing key points including indications, directions for use, adverse reactions and the package insert.
This article compiles basic information on Hyalein ophthalmic solution 0.1%. Its indications include diseases involving keratoconjunctival epithelial disorders, as well as postoperative and external diseases.
The directions specify 1 drop per administration, instilled 5–6 times daily, with adjustments according to symptoms. The 0.1% formulation is normally administered, while the 0.3% formulation is used when the effect is insufficient.
The principal adverse reactions include ocular itching, irritation, eye discharge and conjunctival hyperemia. Corneal disorders and ocular pain have also been reported.
The package insert sets out precautions concerning administration to pregnant or breastfeeding women, the status of clinical trials in children, prevention of contamination of the solution, instructions for instillation and the interval required when using other eye drops.
The information also highlights that drug information, including storage precautions such as keeping the product at room temperature, the diseases covered by the package insert, precautions for use and considerations for pregnant or breastfeeding women and children, is updated as needed.